share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰制药 | 4:持股变动声明-董事 SACHS BRUCE I
美股SEC公告 ·  07/17 16:17

Moomoo AI 已提取核心信息

Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction involving the company's shares on July 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares Sachs held after the transaction remains unknown.
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction involving the company's shares on July 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Consequently, the number of shares Sachs held after the transaction remains unknown.
Bruce I. Sachs与Vertex Pharmaceuticals Inc. (VRTX)有关,于2024年7月15日进行了一项涉及该公司股票的交易。该公告未披露交易的具体细节,包括股份数量、股票性质、交易价格以及股票总价值。交易类型和交易状态也没有提供。因此,Sachs在交易后持有的股票数量仍然未知。
Bruce I. Sachs与Vertex Pharmaceuticals Inc. (VRTX)有关,于2024年7月15日进行了一项涉及该公司股票的交易。该公告未披露交易的具体细节,包括股份数量、股票性质、交易价格以及股票总价值。交易类型和交易状态也没有提供。因此,Sachs在交易后持有的股票数量仍然未知。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息